Le Yu, Kewei Chen, Min Lu, Shaohui Deng, Ye Yan, Jianfei Ye, Fan Zhang, Shudong Zhang
{"title":"Factors Associated With Upgrades From Biopsy Gleason Grades 1–3 to Radical Prostatectomy Gleason Grades 4–5 in Prostate Cancer Patients","authors":"Le Yu, Kewei Chen, Min Lu, Shaohui Deng, Ye Yan, Jianfei Ye, Fan Zhang, Shudong Zhang","doi":"10.1155/ecc/9940460","DOIUrl":null,"url":null,"abstract":"<div>\n <p><b>Introduction:</b> Discordances of Gleason grade (GG) between biopsy and radical prostatectomy (RP) of prostate cancer (PCa) patients have raised great concerns. Our study aimed to identify these predictive factors for GG upgrading from biopsy to RP.</p>\n <p><b>Methods:</b> We retrospectively reviewed the records of PCa patients receiving RP in our medical center. All patients underwent a standardized 12-core transrectal ultrasound (TRUS)–guided prostate needle biopsy, with site-specific submissions. Pretreatment PSA–related parameters were assessed 2 weeks before the operation. Prostate volume (PV) was calculated from images.</p>\n <p><b>Results:</b> 679 patients were enrolled after screening. In the biopsy GG 1–3 group, 91 patients experienced upgrades. The multivariable analysis revealed that total PSA (tPSA) (<i>p</i> value < 0.01) and perineural invasion (<i>p</i> value = 0.01) were significantly associated with the likelihood of upgrading compared to the concordant group.</p>\n <p><b>Conclusion:</b> The GG 4 group demonstrated the lowest rate of concordance between biopsy and RP. Our analysis identified tPSA levels and perineural invasion as independent predictors of GG upgrading from biopsy GG 1–3 to RP GG 4–5 in PCa patients.</p>\n </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/9940460","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer Care","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ecc/9940460","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Discordances of Gleason grade (GG) between biopsy and radical prostatectomy (RP) of prostate cancer (PCa) patients have raised great concerns. Our study aimed to identify these predictive factors for GG upgrading from biopsy to RP.
Methods: We retrospectively reviewed the records of PCa patients receiving RP in our medical center. All patients underwent a standardized 12-core transrectal ultrasound (TRUS)–guided prostate needle biopsy, with site-specific submissions. Pretreatment PSA–related parameters were assessed 2 weeks before the operation. Prostate volume (PV) was calculated from images.
Results: 679 patients were enrolled after screening. In the biopsy GG 1–3 group, 91 patients experienced upgrades. The multivariable analysis revealed that total PSA (tPSA) (p value < 0.01) and perineural invasion (p value = 0.01) were significantly associated with the likelihood of upgrading compared to the concordant group.
Conclusion: The GG 4 group demonstrated the lowest rate of concordance between biopsy and RP. Our analysis identified tPSA levels and perineural invasion as independent predictors of GG upgrading from biopsy GG 1–3 to RP GG 4–5 in PCa patients.
期刊介绍:
The European Journal of Cancer Care aims to encourage comprehensive, multiprofessional cancer care across Europe and internationally. It publishes original research reports, literature reviews, guest editorials, letters to the Editor and special features on current issues affecting the care of cancer patients. The Editor welcomes contributions which result from team working or collaboration between different health and social care providers, service users, patient groups and the voluntary sector in the areas of:
- Primary, secondary and tertiary care for cancer patients
- Multidisciplinary and service-user involvement in cancer care
- Rehabilitation, supportive, palliative and end of life care for cancer patients
- Policy, service development and healthcare evaluation in cancer care
- Psychosocial interventions for patients and family members
- International perspectives on cancer care